| Members |
targetComponentId |
| Closed skull fracture with other and unspecified intracranial hemorrhage |
Closed skull fracture with intracranial hemorrhage |
| Lukket luksation i rygsøjlen med torakal anterior rygmarvslæsion |
Anterior lesion of thoracic spinal cord due to closed dislocation of joint of thoracic spine (disorder) |
| lukket luksation i rygsøjlen med central cervikal rygmarvslæsion |
Central cord syndrome of cervical spinal cord due to closed dislocation of cervical spine (disorder) |
| Lukket luksation i rygsøjlen med central lumbal rygmarvslæsion |
Central cord syndrome of lumbar spinal cord due to closed spinal dislocation (disorder) |
| Lukket luksation i rygsøjlen med central torakal rygmarvslæsion |
Central cord syndrome of thoracic spinal cord due to closed dislocation of joint of thoracic spine (disorder) |
| Lukket luksation i rygsøjlen med torakal posterior rygmarvslæsion |
Posterior cord syndrome of thoracic spinal cord due to closed dislocation of joint of thoracic spine (disorder) |
| lukket luksation af rygsøjlen med torakal rygmarvslæsion, uspecificeret |
Lesion of thoracic spinal cord due to closed dislocation of joint of thoracic spine |
| lukket rygsøjlefraktur med cervikal central medullalæsion, C1-4 |
Central cord syndrome of cervical spinal cord due to closed fracture at C1-C4 level (disorder) |
| lukket rygsøjlefraktur med cervikal central medullalæsion, C5-7 |
Central cord syndrome of cervical spinal cord due to closed fracture at C5-C7 level (disorder) |
| Lukket rygsøjlefraktur med central medullalæsion |
Central cord syndrome of lumbar spinal cord due to closed spinal fracture (disorder) |
| Lukket rygsøjlefraktur med læsion af midterste torakale rygmarv, T1-6 |
Central cord syndrome of thoracic spinal cord due to closed fracture at T1-T6 level (disorder) |
| Lukket rygsøjlefraktur med torakal central medullalæsion, T7-12 |
Central cord syndrome of thoracic spinal cord due to closed fracture at T7-T12 level (disorder) |
| Lukket spinal subluksation med torakal anterior rygmarvslæsion |
Anterior lesion of thoracic spinal cord due to closed subluxation of joint of thoracic spine (disorder) |
| Lukket spinal subluksation med central cervikal rygmarvslæsion |
Central cord syndrome of cervical spinal cord due to closed subluxation of cervical spine (disorder) |
| Lukket spinal subluksation med lumbal central rygmarvslæsion |
Central cord syndrome of lumbar spinal cord due to closed spinal subluxation (disorder) |
| Lukket spinal subluksation med torakal central rygmarvslæsion |
Central cord syndrome of thoracic spinal cord due to closed subluxation of joint of thoracic spine |
| Lukket spinal subluksation med torakal komplet rygmarvslæsion |
Complete lesion of thoracic spinal cord due to closed subluxation of joint of thoracic spine (disorder) |
| Lukket spinal subluksation med torakal posterior rygmarvslæsion |
Posterior cord syndrome of thoracic spinal cord due to closed subluxation of joint of thoracic spine (disorder) |
| Lukket subluksation af rygsøjlen med torakal rygmarvslæsion, uspecificeret |
Lesion of thoracic spinal cord due to subluxation of joint of thoracic spine (disorder) |
| Skabsbøsse |
Homosexual (finding) |
| Clostridium absonum |
Clostridium sardiniense |
| Clostridium barkeri |
Eubacterium barkeri |
| Clostridium botulinum-toxin type B 5000 enheder/ml injektionsvæske, opløsning, ampul a 2 ml |
RimabotulinumtoxinB 5000 unit/mL solution for injection |
| Clostridium botulinum, type G |
Clostridium argentiense |
| Clostridium bryantii |
Syntrophospora bryantii |
| Clostridium durum |
Paenibacillus azotofixans |
| Clostridium fervidus |
Caloramator fervidus |
| Clostridium hydroxybenzoicum |
Sedimentibacter hydroxybenzoicus (organism) |
| Clostridium laramiense |
Clostridium estertheticum subspecies laramiense (organism) |
| Clostridium orbiscindens |
Flavonifractor plautii (organism) |
| Clostridium pfennigii |
Oxobacter pfennigii (organism) |
| Clostridium quercicolum |
Dendrosporobacter quercicolus (organism) |
| Clostridium sartagoformum |
Clostridium sartagoforme (organism) |
| Clostridium thermoaceticum |
Moorella thermoacetica |
| Clostridium thermoautotrophicum |
Moorella thermoautotrophica |
| Clostridium thermocopriae |
Thermoanaerobacter thermocopriae (organism) |
| Clostridium thermolacticum |
Thermoclostridium stercorarium subspecies thermolacticum (organism) |
| Clostridium thermosaccarolyticum |
Thermoanaerobacterium thermosaccharolyticum |
| Clostridium thermosaccharolyticum |
Thermoanaerobacterium thermosaccharolyticum |
| Clostridium thermosulfurigenes |
Thermoanaerobacterium thermosulfurigenes |
| Clostridium villosum |
Filifactor villosus |
| Closure by clamp |
Application of clamp (procedure) |
| Closure of artificial opening of small intestine |
Closure of stoma of small intestine |
| Lukning af defekt ved uspecificeret septum i hjertet |
Operation on cardiac septum |
| Closure of defect of unspecified septum of heart |
Operation on cardiac septum |
| Lukning af defekt ved uspecificeret septum i hjertet, ikke nærmere specificeret |
Operation on cardiac septum |
| Closure of enterovesical fistula |
Repair of fistula involving urinary bladder and intestine (procedure) |
| Closure of fistula |
Closure - action |
| Closure of ileorectal fistula |
Repair of ileorectal fistula |
| Clotrimazole 1% conventional release eye drops |
Clotrimazole only product in ocular dose form |
| clotrimazol 1 % øjendråber uden konserveringsmiddel |
Clotrimazole only product in ocular dose form |
| clotrimazol 100 mg vagitorium |
Product containing precisely clotrimazole 100 milligram/1 each conventional release vaginal tablet (clinical drug) |
| clotrimazol tablet 10 mg |
Product containing precisely clotrimazole 10 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
| Clotrimazole 2%+10% cream+applicator |
Product containing only clotrimazole (medicinal product) |
| clotrimazol 2 % + 10 % creme + applikator |
Product containing only clotrimazole (medicinal product) |
| clotrimazol 200 mg vagitorium |
Product containing precisely clotrimazole 200 milligram/1 each conventional release vaginal tablet (clinical drug) |
| clotrimazol 200 mg/1 % suppositorium + creme |
Product containing only clotrimazole (medicinal product) |
| clotrimazol 500 mg vagitorium |
Clotrimazole 500 mg vaginal tablet |
| clotrimazol 500 mg/2 % vagitorium + creme |
Product containing only clotrimazole (medicinal product) |
| cloxacillinnatrium 125 mg/5 ml oral opløsning |
Product containing precisely cloxacillin (as cloxacillin sodium) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Clozapinmonitorering |
Monitoring of clozapine therapy |
| Co - cobalt- i kosten |
Cobalt |
| co-beneldopa 12,5 mg/50 mg dispergibel tablet |
Benserazide 12.5 mg and levodopa 50 mg oral tablet |
| co-beneldopa 25 mg/100 mg dispergibel tablet |
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
| co-beneldopa kapsel med modificeret udløsning a 25 mg/100 mg |
Product containing only benserazide and levodopa (medicinal product) |
| Co-beneldopa 25mg/100mg prolonged-release oral capsule |
Product containing only benserazide and levodopa (medicinal product) |
| Co-careldopa 10mg/100mg tablet |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-careldopa 25mg/100mg m/r tablet |
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
| Co-careldopa 25mg/100mg tablet |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet |
| Co-careldopa 25mg/250mg tablet |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) |
| Co-careldopa 50mg/200mg m/r tablet |
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
| co-codamol 8 mg + 500 mg dispergibel tablet |
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
| Co-codaprin 8mg/500mg dispersible tablet |
Aspirin and codeine only product in oral dose form |
| co-trimoxazol 160 mg/800 mg dispergibel tablet |
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
| Co-trimoxazole 16mg/80mg/mL infusion solution 10mL ampule |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
| co-trimoxazol 80 mg/400 mg dispergibel tablet |
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
| co-trimoxazol 960 mg/10 ml infusionsvæske til intravenøs anvendelse |
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL solution for injection |
| Coag./bleeding test NOS |
Laboratory test related to hemostasis |
| Coag./bleeding test NOS |
Laboratory test related to hemostasis |
| Coagulation Factor VIIa (cattle) |
Coagulation factor VIIa |
| Coagulation Factor XIIa |
Coagulation factor XIIa |
| Coagulation Factor XIa |
Coagulation factor XIa |
| Coagulation Factor Xa |
Coagulation factor Xa |
| Coagulation factor IV |
Calcium |
| Coagulation factor IXa |
Coagulation factor IXa |
| kultjære 10 % præparat til pensling |
Coal tar 100 mg/mL cutaneous solution |
| kultjære 30 % badeemulsion |
Product containing precisely coal tar 300 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| kultjære 40 % badeemulsion |
Product containing precisely coal tar 400 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
| Coal tar 40% conventional release cutaneous solution |
Product containing only coal tar in cutaneous dose form (medicinal product form) |
| kultjæreekstrakt 2 % shampoo |
Product containing precisely coal tar 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
| kultjæresalve |
Coal tar |
| kultjæreopløsning til topikal anvendelse |
Coal tar |
| ikke-farmaceutisk cocain |
Cocaine (substance) |
| farmaceutisk cocain |
Cocaine (substance) |
| cocain 10 % næsedråber |
Cocaine 100 mg/mL nasal solution |
| cocain 20 % øjendråber |
Cocaine (as cocaine hydrochloride) 200 mg/mL eye solution |
| Cocaine 4% conventional release eye drops |
Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
| cocain 4 % øjendråber uden konserveringsmiddel |
Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
| cocain 5 % øjendråber |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Cocaine dependence with current use |
Cocaine dependence |
| ikke-farmaceutisk cocainhydrochlorid |
Cocaine hydrochloride |
FHIR